The Lunai Platform

Prediction meets proof

Traditional drug discovery separates computation from validation. Lunai closes that gap with a continuous system:

Augusta - AI/ML Engine

Integrates genomic, proteomic, and phenotypic data to uncover signatures conventional methods miss. Identifies biomarkers and targets grounded in translational relevance.

Phenograph – Translational System

Maps computational insights to therapeutic strategies. Prioritizes based on druggability, patient stratification, and clinical feasibility, creating a direct route from data to patient benefit.

In Vivo Modeling – Zebrafish + Machine Vision

Combines living zebrafish models with AI-powered analysis. Captures behavioral, morphological, and physiological responses at scale, uncovering mechanisms and treatment effects that static models cannot.

Together, these components form a closed loop: discovery, translation, validation, reducing risk, compressing timelines, and raising confidence in therapeutic success.

Applications Across Medicine

Expertise in:

1
Oncology
Uncover predictive biomarkers that reveal who will respond to immunotherapies and targeted therapies. Anticipate resistance mechanisms earlier, guiding more durable treatment strategies.
2
Neurology
Decode complex disorders like epilepsy by integrating molecular, electrical, and behavioral signals. Model disease progression and treatment response in ways that traditional systems cannot.
3
Biosecurity
Extend discovery beyond medicine. Rapidly assess neurotoxic effects of chemicals, enabling faster countermeasures and stronger resilience against global health threats.